Preoperative lymph-node staging of invasive urothelial bladder cancer with ¹⁸F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: Correlation with histopathology

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin 2009;59:225–49.
   PubMed Web of Science ®Google Scholar
• Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374:239–49.
   PubMed Web of Science ®Google Scholar
• MacVicar AD. Bladder cancer staging. BJU Int 2000;86(Suppl 1):111–22.
   PubMedGoogle Scholar
• Barocas DA, Clark PE. Bladder cancer. Curr Opin Oncol 2008;20:307–14.
   PubMed Web of Science ®Google Scholar
• Beyersdorff D, Zhang J, Schoder H, Bochner B, Hricak H. Bladder cancer: can imaging change patient management? Curr Opin Urol 2008;18:98–104.
   PubMed Web of Science ®Google Scholar
• Setty BN, Holalkere NS, Sahani DV, Uppot RN, Harisinghani M, Blake MA. State-of-the-art cross-sectional imaging in bladder cancer. Curr Probl Diagn Radiol 2007;36:83–96.
   PubMedGoogle Scholar
• Bouchelouche K, Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol 2008;179:34–45.
   PubMed Web of Science ®Google Scholar
• Powles T, Murray I, Brock C, Oliver T, Avril N. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007;51:1511–21.
   PubMed Web of Science ®Google Scholar
• Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med 2006;36:51–72.
   PubMed Web of Science ®Google Scholar
• Kosuda S, Kison PV, Greenough R, Grossman HB, Wahl RL. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 1997;24:615–20.
   PubMedGoogle Scholar
• Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med 2007;48:764–70.
   PubMed Web of Science ®Google Scholar
• Steven K, Poulsen AL. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 2007;178:1218–23.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666–75.
   PubMed Web of Science ®Google Scholar
• Newcombe RG, Altman DG. Proportions and their differences. In: Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with confidence. 2nd ed. London: BMJ Books; 2000.
   Google Scholar
• Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004;233:449–56.
   PubMed Web of Science ®Google Scholar
• Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005;32:1412–17.
   PubMed Web of Science ®Google Scholar
• Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 2009;57:641–7.
   PubMed Web of Science ®Google Scholar
• Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009;27:4314–20.
   PubMed Web of Science ®Google Scholar
• Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22:4357–68.
   PubMed Web of Science ®Google Scholar
• de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. Visualisation of bladder cancer using 11C-choline PET: first clinical experience. Eur J Nucl Med Mol Imaging 2002;29:1283–8.
   PubMed Web of Science ®Google Scholar
• Picchio M, Treiber U, Beer AJ, Metz S, Bossner P, van Randenborgh H, Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 2006;47:938–44.
   PubMed Web of Science ®Google Scholar
• Ahlstrom H, Malmstrom PU, Letocha H, Andersson J, Langstrom B, Nilsson S. Positron emission tomography in the diagnosis and staging of urinary bladder cancer. Acta Radiol 1996;37:180–5.
   PubMed Web of Science ®Google Scholar
• Liu IJ, Lai YH, Espiritu JI, Segall GM, Srinivas S, Nino-Murcia M, Evaluation of fluorodeoxyglucose positron emission tomography imaging in metastatic transitional cell carcinoma with and without prior chemotherapy. Urol Int 2006;77:69–75.
   PubMed Web of Science ®Google Scholar